major depressive disorder
Showing NaN - NaN of 111
MDD Trial in Boston (Riluzole, Sertraline, )
Terminated
- Major Depressive Disorder
- Riluzole
- +2 more
-
Boston, MassachusettsBrigham and Women's Hospital
Aug 9, 2019
MDD Trial in Puerto Rico, United States (Cariprazine, Antidepressant Therapy (ADT))
Completed
- Major Depressive Disorder
- Cariprazine
- Antidepressant Therapy (ADT)
-
Tucson, Arizona
- +89 more
Jul 29, 2019
MDD Trial in United States (ALKS 5461, Placebo)
Completed
- Major Depressive Disorder
- ALKS 5461
- Placebo
-
Tucson, Arizona
- +26 more
Apr 26, 2019
MDD Trial in Gaithersburg, Boston, Dayton (SHX-001 Active low dose, Placebo, SHX-001 Active High dose)
Unknown status
- Major Depressive Disorder
- SHX-001 Active low dose
- +2 more
-
Gaithersburg, Maryland
- +2 more
Apr 24, 2019
Depression, Anxious Depression, MDD Trial in Boston (Ketamine, Magnetic Resonance Imaging (MRI))
Completed
- Depression
- +2 more
- Ketamine
- Magnetic Resonance Imaging (MRI)
-
Boston, MassachusettsMassachusetts General Hospital
Apr 3, 2019
MDD Trial in Boston (Ganaxolone)
Completed
- Major Depressive Disorder
-
Boston, MassachusettsMassachusetts General Hospital
Feb 13, 2019
MDD Trial in Boston (250 mg DCS, 100 mg Modafinil, Placebo)
Completed
- Major Depressive Disorder
- 250 mg DCS
- +2 more
-
Boston, MassachusettsBoston University
Aug 22, 2018
Depression and Dopamine Transporter Function Study Using C-11
Completed
- Major Depressive Disorder
- Anhedonia
-
Belmont, Massachusetts
- +1 more
May 18, 2018
Exploring Biomarkers for Depression
Completed
- Major Depressive Disorder
- Escitalopram
- Healthy Control
-
Boston, MassachusettsDepression Clinical and Research Program, MGH
Apr 30, 2018
MDD Trial in Worldwide (LY2216684, Placebo, SSRI)
MDD Trial in Boston (Ketamine, Scopolamine)
Withdrawn
- Major Depressive Disorder
-
Boston, MassachusettsDepression Clinical and Reseach Program - MGH
Feb 15, 2018
MDD Trial in Boston (Cognitive Behavioral Therapy (CBT), Escitalopram)
Completed
- Major Depressive Disorder
- Cognitive Behavioral Therapy (CBT)
- Escitalopram
-
Boston, MassachusettsMassachusetts General Hospital
Dec 7, 2017
MDD Trial in Boston, Chelsea (Near-infrared radiation via Transcranial LED Therapy, Sham device)
Completed
- Major Depressive Disorder
- Near-infrared radiation via Transcranial LED Therapy
- Sham device
-
Boston, Massachusetts
- +1 more
Oct 24, 2017
MDD Trial in Boston (Aripiprazole 5mg, Aripiprazole 2mg, Placebo)
Completed
- Major Depressive Disorder
- Aripiprazole 5mg
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Jun 21, 2017
MDD Trial in Boston (drug, other, procedure)
Terminated
- Major Depressive Disorder
- ketamine
- +4 more
-
Boston, MassachusettsMassachusetts General Hospital
Apr 18, 2017
MDD Trial in Boston (Escitalopram 10mg, Placebo)
Terminated
- Major Depressive Disorder
- Escitalopram 10mg
- Placebo
-
Boston, MassachusettsMassachusetts General Hospital Depression Clinical and Research
Apr 18, 2017
MDD Trial in Boston (Amphetamine/dextroamphetamine, Placebo, Well-being therapy)
Terminated
- Major Depressive Disorder
- Amphetamine/dextroamphetamine
- +2 more
-
Boston, MassachusettsDepression Clinical and Research Program
Mar 16, 2017
MDD Trial in Boston (Ketamine, Placebo)
Completed
- Major Depressive Disorder
- Ketamine
- Placebo
-
Boston, MassachusettsDepression Clinical and Reseach Program - MGH
Apr 18, 2017
MDD Trial in Boston (Ketamine)
Completed
- Major Depressive Disorder
-
Boston, MassachusettsDepression Clinical and Research Program - MGH
Apr 18, 2017
MDD Trial in Worldwide (AZD6765 iv, Placebo)
Completed
- Major Depressive Disorder
- AZD6765 iv
- Placebo
-
Chino, California
- +43 more
Apr 10, 2017
MDD Trial in Boston (Iloperidone, Placebo)
Completed
- Major Depressive Disorder
- Iloperidone
- Placebo
-
Boston, MassachusettsMassachusetts General Hospital
Feb 28, 2017
Brain Network Activation Analysis to Diagnose Major Depression
Terminated
- Major Depressive Disorder
-
Boston, MassachusettsDepression Clinical and Research Program
Mar 2, 2017
MDD, Depression, Unipolar, Recurrence Trial in Boston (Naltrexone, Placebo)
Completed
- Major Depressive Disorder
- +3 more
- Naltrexone
- Placebo
-
Boston, MassachusettsMassachusetts General Hospital; Depression Research and Clinical
Jan 5, 2017
Insulin Resistance and Metabolic Syndrome Between Major
Terminated
- Major Depressive Disorder
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Feb 10, 2017
MDD Trial in Boston (Escitalopram)
Completed
- Major Depressive Disorder
-
Boston, MassachusettsDepression Clinical and Research Program, Massachusetts General
Nov 4, 2016